Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Savara Inc (SVRA)

$5.51 -4.17% NASDAQ: SVRA · 15-min delayed
  • AUSTIN, Texas
  • Public · NASDAQ: SVRA
  • 70 employees
$1.0BMarket cap
$257.0KRevenue · FY2020
-$118.8MNet income
70Employees
SVRANASDAQ
1996IPO

About Savara Inc

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2020
$257.0K
Net income
-$118.8M
Total assets
$253.4M
Market cap
$1.0B

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating expenses
$123.5M
Operating income
-$123.5M
Income tax
$0
Net income
-$118.8M
EPS (basic)
$-0.53
EPS (diluted)
$-0.53

Balance sheet

Total assets
$253.4M
Current assets
$241.6M
Total liabilities
$50.3M
Current liabilities
$20.4M
Shareholders’ equity
-$87.0K

Cash flow

Operating cash flow
-$101.0M
Investing cash flow
-$18.4M
Financing cash flow
$137.8M
Net cash flow
$18.3M

Statements via Polygon.io (SEC filings)

NASDAQ: SVRA
$5.51 -4.17%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.05 $6.94

52-week range

Market cap
$1.0B
EPS (diluted)
$-0.53
Shares outstanding
189.3M
Open
Day range
Prev close
Volume
IPO date
Nov 18, 1996

Savara Inc (SVRA) Stock Price

  • Reported a net loss of $118.8M in FY2020.
  • Trading 21% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Savara Inc.

Write a review
Newsroom

News about Savara Inc

News & sentiment via Polygon.io

FAQ

Savara Inc: frequently asked questions

Is Savara Inc an American company?

Savara Inc is a US-based company headquartered in Austin, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Savara Inc headquartered?

Savara Inc is headquartered in Austin, Texas, United States.

Is Savara Inc publicly traded?

Yes — Savara Inc is a publicly traded company. Its stock trades under the ticker symbol SVRA on the NASDAQ.

What does Savara Inc do?

Savara Inc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →